Moderna, Inc.
MRNANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 31, 2026Score 5/30567% above fair value
$220.83−0.89 (-0.40%)
Close on Nov 2, 2026Market cap $88.16BP/E –Yield –
Moderna Countries with Moderna employees (countries) by Year
Moderna Countries with Moderna employees (countries): 18.00 countries in FY2025, unchanged from a year earlier.
Latest, FY2025
18.00
Period ended Dec 31, 2025
Change on a year earlier
0.0%
18.00 in FY2024
History
5 years
Since FY2021
Sources
5
Documents cited below
Where the FY2025 figure comes from
“We had approximately 4,700 full-time employees in 18 countries as of December 31, 2025 .”
Source: FY2025 10-K ↗
Reported in Form 10-K Item 1 (Human Capital Management).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Countries with Moderna employees (countries) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 18.00 | 0.0% | FY2025 10-K ↗ |
| FY2024 | Dec 31, 2024 | 18.00 | -5.3% | FY2024 10-K ↗ |
| FY2023 | Dec 31, 2023 | 19.00 | +11.8% | FY2023 10-K ↗ |
| FY2022 | Dec 31, 2022 | 17.00 | +41.7% | FY2022 10-K ↗ |
| FY2021 | Dec 31, 2021 | 12.00 | – | FY2021 10-K ↗ |
Cite this data
StockData. (2026). Moderna Countries with Moderna employees (countries), annual FY2021–FY2025 [Data set]. Compiled from Moderna SEC filings and investor materials. https://stockdatahq.com/stocks/mrna/kpis/hc-countries
See every metric in the Moderna KPI table. Data updated Nov 3, 2026.